Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 441

1.

Quantification of Small Fiber Neuropathy in Chemotherapy Treated Patients.

Timmins HC, Li T, Kiernan MC, Horvath LG, Goldstein D, Park SB.

J Pain. 2019 Jul 17. pii: S1526-5900(19)30765-5. doi: 10.1016/j.jpain.2019.06.011. [Epub ahead of print] Review.

PMID:
31325646
2.

Neuroinflammation in frontotemporal dementia.

Bright F, Werry EL, Dobson-Stone C, Piguet O, Ittner LM, Halliday GM, Hodges JR, Kiernan MC, Loy CT, Kassiou M, Kril JJ.

Nat Rev Neurol. 2019 Jul 19. doi: 10.1038/s41582-019-0231-z. [Epub ahead of print] Review.

PMID:
31324897
3.

Motor neuron disease with malignancy: Clinical and pathophysiological insights.

Higashihara M, Menon P, Geevasinga N, Van den Bos MAJ, Kiernan MC, Vucic S.

Clin Neurophysiol. 2019 Jun 22;130(9):1557-1561. doi: 10.1016/j.clinph.2019.05.026. [Epub ahead of print]

PMID:
31301633
4.

Safety and tolerability of Triumeq in amyotrophic lateral sclerosis: the Lighthouse trial.

Gold J, Rowe DB, Kiernan MC, Vucic S, Mathers S, van Eijk RPA, Nath A, Garcia Montojo M, Norato G, Santamaria UA, Rogers ML, Malaspina A, Lombardi V, Mehta PR, Westeneng HJ, van den Berg LH, Al-Chalabi A.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Jul 8:1-10. doi: 10.1080/21678421.2019.1632899. [Epub ahead of print]

PMID:
31284774
5.

Amyotrophic lateral sclerosis as a multi-step process: an Australia population study.

Vucic S, Westeneng HJ, Al-Chalabi A, Van Den Berg LH, Talman P, Kiernan MC.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Jul 8:1-6. doi: 10.1080/21678421.2018.1556697. [Epub ahead of print]

PMID:
31284763
6.

Recent Developments in TSPO PET Imaging as A Biomarker of Neuroinflammation in Neurodegenerative Disorders.

Werry EL, Bright FM, Piguet O, Ittner LM, Halliday GM, Hodges JR, Kiernan MC, Loy CT, Kril JJ, Kassiou M.

Int J Mol Sci. 2019 Jun 28;20(13). pii: E3161. doi: 10.3390/ijms20133161. Review.

7.

Amyotrophic lateral sclerosis: Origins traced to impaired balance between neural excitation and inhibition in the neonatal period.

Kiernan MC, Ziemann U, Eisen A.

Muscle Nerve. 2019 Jun 24. doi: 10.1002/mus.26617. [Epub ahead of print]

PMID:
31233613
8.

Marco Polo of Australian neurology.

Kiernan MC, Goadsby PJ, Burke D.

J Neurol Neurosurg Psychiatry. 2019 Jun;90(6):627-628. doi: 10.1136/jnnp-2019-320989. Epub 2019 May 2. No abstract available.

PMID:
31048340
9.

Patient Editorial Board for JNNP.

Riggare S, Thurbon R, Roman S, Richards T, Kiernan MC.

J Neurol Neurosurg Psychiatry. 2019 Apr;90(4):369-370. doi: 10.1136/jnnp-2019-320453. No abstract available.

PMID:
30967489
10.

Eating peptides: biomarkers of neurodegeneration in amyotrophic lateral sclerosis and frontotemporal dementia.

Ahmed RM, Phan K, Highton-Williamson E, Strikwerda-Brown C, Caga J, Ramsey E, Zoing M, Devenney E, Kim WS, Hodges JR, Piguet O, Halliday GM, Kiernan MC.

Ann Clin Transl Neurol. 2019 Jan 31;6(3):486-495. doi: 10.1002/acn3.721. eCollection 2019 Mar.

11.

Conduction block in immune-mediated neuropathy: paranodopathy versus axonopathy.

Garg N, Park SB, Howells J, Vucic S, Yiannikas C, Mathey EK, Nguyen T, Noto Y, Barnett MH, Krishnan AV, Spies J, Bostock H, Pollard JD, Kiernan MC.

Eur J Neurol. 2019 Aug;26(8):1121-1129. doi: 10.1111/ene.13953. Epub 2019 Apr 26.

PMID:
30882969
12.

The underacknowledged PPA-ALS: A unique clinicopathologic subtype with strong heritability.

Tan RH, Guennewig B, Dobson-Stone C, Kwok JBJ, Kril JJ, Kiernan MC, Hodges JR, Piguet O, Halliday GM.

Neurology. 2019 Mar 19;92(12):e1354-e1366. doi: 10.1212/WNL.0000000000007146. Epub 2019 Feb 15.

PMID:
30770429
13.

Measuring network disruption in neurodegenerative diseases: New approaches using signal analysis.

McMackin R, Muthuraman M, Groppa S, Babiloni C, Taylor JP, Kiernan MC, Nasseroleslami B, Hardiman O.

J Neurol Neurosurg Psychiatry. 2019 Feb 13. pii: jnnp-2018-319581. doi: 10.1136/jnnp-2018-319581. [Epub ahead of print]

14.

The effect of coil type and limb dominance in the assessment of lower-limb motor cortex excitability using TMS.

Dharmadasa T, Matamala JM, Howells J, Simon NG, Vucic S, Kiernan MC.

Neurosci Lett. 2019 Apr 23;699:84-90. doi: 10.1016/j.neulet.2019.01.050. Epub 2019 Jan 30.

PMID:
30710665
15.

Amyotrophic lateral sclerosis diagnostic index: Toward a personalized diagnosis of ALS.

Geevasinga N, Howells J, Menon P, van den Bos M, Shibuya K, Matamala JM, Park SB, Byth K, Kiernan MC, Vucic S.

Neurology. 2019 Feb 5;92(6):e536-e547. doi: 10.1212/WNL.0000000000006876. Epub 2019 Jan 11.

PMID:
30709964
16.

Clinical and neuroimaging investigations of language disturbance in frontotemporal dementia-motor neuron disease patients.

Long Z, Irish M, Piguet O, Kiernan MC, Hodges JR, Burrell JR.

J Neurol. 2019 Apr;266(4):921-933. doi: 10.1007/s00415-019-09216-0. Epub 2019 Feb 1.

PMID:
30707358
17.

Vasculitic neuropathy: Comparison of clinical predictors with histopathological outcome.

Nathani D, Barnett MH, Spies J, Pollard J, Wang MX, Kiernan MC.

Muscle Nerve. 2019 Jun;59(6):643-649. doi: 10.1002/mus.26431. Epub 2019 Feb 23.

PMID:
30702153
18.

Cerebellar tract alterations in PLS and ALS.

Tu S, Menke RAL, Talbot K, Kiernan MC, Turner MR.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 May;20(3-4):281-284. doi: 10.1080/21678421.2018.1562554. Epub 2019 Jan 21.

PMID:
30663900
19.

Functional Biomarkers for Amyotrophic Lateral Sclerosis.

Huynh W, Dharmadasa T, Vucic S, Kiernan MC.

Front Neurol. 2019 Jan 4;9:1141. doi: 10.3389/fneur.2018.01141. eCollection 2018. Review.

20.

Predictors of survival and progression in behavioural variant frontotemporal dementia.

Agarwal S, Ahmed RM, D'Mello M, Foxe D, Kaizik C, Kiernan MC, Halliday GM, Piguet O, Hodges JR.

Eur J Neurol. 2019 May;26(5):774-779. doi: 10.1111/ene.13887. Epub 2019 Jan 29.

PMID:
30565360
21.

Utility of threshold tracking transcranial magnetic stimulation in ALS.

Vucic S, van den Bos M, Menon P, Howells J, Dharmadasa T, Kiernan MC.

Clin Neurophysiol Pract. 2018 Nov 17;3:164-172. doi: 10.1016/j.cnp.2018.10.002. eCollection 2018. Review.

22.

Frontostriatal grey matter atrophy in amyotrophic lateral sclerosis A visual rating study.

Radakovic R, Puthusseryppady V, Flanagan E, Kiernan MC, Mioshi E, Hornberger M.

Dement Neuropsychol. 2018 Oct-Dec;12(4):388-393. doi: 10.1590/1980-57642018dn12-040008.

23.

Motor neurone disease.

Dharmadasa T, Matamala JM, Huynh W, Zoing MC, Kiernan MC.

Handb Clin Neurol. 2018;159:345-357. doi: 10.1016/B978-0-444-63916-5.00022-7. Review.

PMID:
30482326
24.

Aerobic exercise training may improve nerve function in type 2 diabetes and pre-diabetes: A systematic review.

Gu Y, Dennis SM, Kiernan MC, Harmer AR.

Diabetes Metab Res Rev. 2019 Feb;35(2):e3099. doi: 10.1002/dmrr.3099. Epub 2018 Dec 7. Review.

PMID:
30462877
25.

The burden of apathy for caregivers of patients with amyotrophic lateral sclerosis.

Caga J, Hsieh S, Highton-Williamson E, Zoing MC, Ramsey E, Devenney E, Ahmed RM, Hogden A, Kiernan MC.

Amyotroph Lateral Scler Frontotemporal Degener. 2018 Nov;19(7-8):599-605. doi: 10.1080/21678421.2018.1497659. Epub 2018 Oct 29.

PMID:
30369270
26.

Imbalance of cortical facilitatory and inhibitory circuits underlies hyperexcitability in ALS.

Van den Bos MAJ, Higashihara M, Geevasinga N, Menon P, Kiernan MC, Vucic S.

Neurology. 2018 Oct 30;91(18):e1669-e1676. doi: 10.1212/WNL.0000000000006438. Epub 2018 Oct 3.

PMID:
30282772
27.

Psychiatric disorders in C9orf72 kindreds: Study of 1,414 family members.

Devenney EM, Ahmed RM, Halliday G, Piguet O, Kiernan MC, Hodges JR.

Neurology. 2018 Oct 16;91(16):e1498-e1507. doi: 10.1212/WNL.0000000000006344. Epub 2018 Sep 26.

PMID:
30258023
28.

Association of Leucine-Rich Glioma Inactivated Protein 1, Contactin-Associated Protein 2, and Contactin 2 Antibodies With Clinical Features and Patient-Reported Pain in Acquired Neuromyotonia.

Vincent A, Pettingill P, Pettingill R, Lang B, Birch R, Waters P, Irani SR, Buckley C, Watanabe O, Arimura K, Kiernan MC.

JAMA Neurol. 2018 Dec 1;75(12):1519-1527. doi: 10.1001/jamaneurol.2018.2681.

29.

Potassium control in chronic kidney disease: implications for neuromuscular function.

Arnold R, Pianta TJ, Pussell BA, Endre Z, Kiernan MC, Krishnan AV.

Intern Med J. 2019 Jul;49(7):817-825. doi: 10.1111/imj.14114. Review.

PMID:
30230667
30.

In vivo evidence for reduced ion channel expression in motor axons of patients with amyotrophic lateral sclerosis.

Howells J, Matamala JM, Park SB, Garg N, Vucic S, Bostock H, Burke D, Kiernan MC.

J Physiol. 2018 Nov;596(22):5379-5396. doi: 10.1113/JP276624. Epub 2018 Oct 17.

PMID:
30175403
31.

Neural correlates of changes in sexual function in frontotemporal dementia: implications for reward and physiological functioning.

Ahmed RM, Goldberg ZL, Kaizik C, Kiernan MC, Hodges JR, Piguet O, Irish M.

J Neurol. 2018 Nov;265(11):2562-2572. doi: 10.1007/s00415-018-9024-3. Epub 2018 Aug 28.

PMID:
30167881
32.

Anti-MAG neuropathy: Role of IgM antibodies, the paranodal junction and juxtaparanodal potassium channels.

Garg N, Park SB, Howells J, Noto YI, Vucic S, Yiannikas C, Tomlinson SE, Huynh W, Simon NG, Mathey EK, Spies J, Pollard JD, Krishnan AV, Kiernan MC.

Clin Neurophysiol. 2018 Oct;129(10):2162-2169. doi: 10.1016/j.clinph.2018.07.021. Epub 2018 Aug 10.

PMID:
30144659
33.

Fasciculation intensity and disease progression in amyotrophic lateral sclerosis.

Tsugawa J, Dharmadasa T, Ma Y, Huynh W, Vucic S, Kiernan MC.

Clin Neurophysiol. 2018 Oct;129(10):2149-2154. doi: 10.1016/j.clinph.2018.07.015. Epub 2018 Aug 2.

PMID:
30114663
34.

Regional thalamic MRI as a marker of widespread cortical pathology and progressive frontotemporal involvement in amyotrophic lateral sclerosis.

Tu S, Menke RAL, Talbot K, Kiernan MC, Turner MR.

J Neurol Neurosurg Psychiatry. 2018 Dec;89(12):1250-1258. doi: 10.1136/jnnp-2018-318625. Epub 2018 Jul 26.

PMID:
30049750
35.

Comparison of cross-sectional areas and distal-proximal nerve ratios in amyotrophic lateral sclerosis.

Noto YI, Garg N, Li T, Timmins HC, Park SB, Shibuya K, Shahrizaila N, Huynh W, Matamala JM, Dharmadasa T, Yiannikas C, Vucic S, Kiernan MC.

Muscle Nerve. 2018 Dec;58(6):777-783. doi: 10.1002/mus.26301. Epub 2018 Oct 15.

PMID:
30019401
36.

Cortical excitability varies across different muscles.

Menon P, Kiernan MC, Vucic S.

J Neurophysiol. 2018 Sep 1;120(3):1397-1403. doi: 10.1152/jn.00148.2018. Epub 2018 Jul 5.

PMID:
29975162
37.

Inflammatory neuropathies: all shapes and sizes.

Garg N, Park SB, Kiernan MC.

J Neurol Neurosurg Psychiatry. 2018 Nov;89(11):1128. doi: 10.1136/jnnp-2018-318513. Epub 2018 Jun 26. No abstract available.

PMID:
29945878
38.

A unified model of the excitability of mouse sensory and motor axons.

Makker PGS, Matamala JM, Park SB, Lees JG, Kiernan MC, Burke D, Moalem-Taylor G, Howells J.

J Peripher Nerv Syst. 2018 Sep;23(3):159-173. doi: 10.1111/jns.12278. Epub 2018 Jul 15.

PMID:
29920851
39.

Primary lateral sclerosis and the amyotrophic lateral sclerosis-frontotemporal dementia spectrum.

Agarwal S, Highton-Williamson E, Caga J, Matamala JM, Dharmadasa T, Howells J, Zoing MC, Shibuya K, Geevasinga N, Vucic S, Hodges JR, Ahmed RM, Kiernan MC.

J Neurol. 2018 Aug;265(8):1819-1828. doi: 10.1007/s00415-018-8917-5. Epub 2018 Jun 4.

PMID:
29868980
40.

Interrogating cortical function with transcranial magnetic stimulation: insights from neurodegenerative disease and stroke.

Agarwal S, Koch G, Hillis AE, Huynh W, Ward NS, Vucic S, Kiernan MC.

J Neurol Neurosurg Psychiatry. 2019 Jan;90(1):47-57. doi: 10.1136/jnnp-2017-317371. Epub 2018 Jun 4. Review.

PMID:
29866706
41.

Correlation between markers of peripheral nerve function and structure in type 1 diabetes.

Borire AA, Issar T, Kwai NC, Visser LH, Simon NG, Poynten AM, Kiernan MC, Krishnan AV.

Diabetes Metab Res Rev. 2018 Oct;34(7):e3028. doi: 10.1002/dmrr.3028. Epub 2018 Jul 3.

PMID:
29858541
42.

Chemotherapy-Induced Peripheral Neuropathy in Long-term Survivors of Childhood Cancer: Clinical, Neurophysiological, Functional, and Patient-Reported Outcomes.

Kandula T, Farrar MA, Cohn RJ, Mizrahi D, Carey K, Johnston K, Kiernan MC, Krishnan AV, Park SB.

JAMA Neurol. 2018 Aug 1;75(8):980-988. doi: 10.1001/jamaneurol.2018.0963.

43.

Amyotrophic lateral sclerosis - Time for beta testing?

Baker MR, Dharmadasa T, Jaiser SR, Kiernan MC.

Clin Neurophysiol. 2018 Jul;129(7):1455-1456. doi: 10.1016/j.clinph.2018.04.613. Epub 2018 Apr 30. No abstract available.

PMID:
29754830
44.

Paradox of amyotrophic lateral sclerosis and energy metabolism.

Ahmed RM, Dupuis L, Kiernan MC.

J Neurol Neurosurg Psychiatry. 2018 Oct;89(10):1013-1014. doi: 10.1136/jnnp-2018-318428. Epub 2018 May 7. No abstract available.

PMID:
29735514
45.

Physiological Processes Underlying Short Interval Intracortical Facilitation in the Human Motor Cortex.

Van den Bos MAJ, Menon P, Howells J, Geevasinga N, Kiernan MC, Vucic S.

Front Neurosci. 2018 Apr 11;12:240. doi: 10.3389/fnins.2018.00240. eCollection 2018.

46.

Implications of structural and functional brain changes in amyotrophic lateral sclerosis.

Dharmadasa T, Huynh W, Tsugawa J, Shimatani Y, Ma Y, Kiernan MC.

Expert Rev Neurother. 2018 May;18(5):407-419. doi: 10.1080/14737175.2018.1464912. Epub 2018 Apr 19. Review.

PMID:
29667443
47.

Human cerebral evolution and the clinical syndrome of amyotrophic lateral sclerosis.

Henderson RD, Garton FC, Kiernan MC, Turner MR, Eisen A.

J Neurol Neurosurg Psychiatry. 2019 May;90(5):570-575. doi: 10.1136/jnnp-2017-317245. Epub 2018 Apr 17. No abstract available.

48.

Excitability of sensory axons in amyotrophic lateral sclerosis.

Matamala JM, Howells J, Dharmadasa T, Huynh W, Park SB, Burke D, Kiernan MC.

Clin Neurophysiol. 2018 Jul;129(7):1472-1478. doi: 10.1016/j.clinph.2018.03.014. Epub 2018 Apr 2.

PMID:
29661595
49.

Selective Spatiotemporal Vulnerability of Central Nervous System Neurons to Pathologic TAR DNA-Binding Protein 43 in Aged Transgenic Mice.

van Hummel A, Chan G, van der Hoven J, Morsch M, Ippati S, Suh L, Bi M, Asih PR, Lee WS, Butler TA, Przybyla M, Halliday GM, Piguet O, Kiernan MC, Chung RS, Ittner LM, Ke YD.

Am J Pathol. 2018 Jun;188(6):1447-1456. doi: 10.1016/j.ajpath.2018.03.002. Epub 2018 Mar 22.

PMID:
29577934
50.

Physiological changes in neurodegeneration - mechanistic insights and clinical utility.

Ahmed RM, Ke YD, Vucic S, Ittner LM, Seeley W, Hodges JR, Piguet O, Halliday G, Kiernan MC.

Nat Rev Neurol. 2018 May;14(5):259-271. doi: 10.1038/nrneurol.2018.23. Epub 2018 Mar 23. Review.

PMID:
29569624

Supplemental Content

Loading ...
Support Center